Advances in experimental and translational research in the treatment of hepatocellular carcinoma
T Kidner, M Dai, PS Adusumilli, Y Fong - Surgical oncology clinics of North …, 2008 - Elsevier
Hepatocellular cancer (HCC) is the fifth-leading cause of cancer and the third-leading cause
of cancer related deaths world-wide. Current treatment options are limited, as HCC has
been shown to be a highly resistant type of cancer to most current treatment modalities.
Novel approaches are being explored in the fields of gene therapy, viral oncolytics,
radioembolization, and several new biologic therapies. This article summarizes these recent
clinical findings and discusses what role they will have in the future treatment of HCC.
of cancer related deaths world-wide. Current treatment options are limited, as HCC has
been shown to be a highly resistant type of cancer to most current treatment modalities.
Novel approaches are being explored in the fields of gene therapy, viral oncolytics,
radioembolization, and several new biologic therapies. This article summarizes these recent
clinical findings and discusses what role they will have in the future treatment of HCC.